Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
It approved Pfizer’s vaccine only for children 5 years and up, and Novavax’s only for children 12 and up, in both cases also with the high-risk limitation.
- Simplified Text
-
FDA approved Pfizer vaccine for children 5+ Novavax for children 12+ both with high-risk limitation
- Confidence Score
- 0.500
- Claim Maker
- The author
- Context Type
- Website Article
- Context Details
-
{ "date": null } - Subject Tags
- UUID
- 9fc8ae9b-b492-41b4-8648-8c3d74a5e061
- Vector Index
- ✗ No vector
- Created
- September 2, 2025 at 7:51 PM (1 week ago)
- Last Updated
- September 2, 2025 at 7:51 PM (1 week ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
33
claims
🔥
1 week ago
https://www.nytimes.com/2025/08/27/well/covid-vaccines-guidelines-fall-2025.html?campaign_id=9&emc=edit_nn_20250901&instance_id=161665&nl=the-morning®i_id=122976029&segment_id=205030&user_id=b25c5730c89e0c73f75709d8f1254337
The FDA has limited COVID-19 vaccine eligibility to those 65+ or with high-risk conditions. Access is complicated, with pharmacies potentially restricting distribution. Doctors may prescribe off-label, but coverage is uncertain.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.